Humana AB Statistics

Total Valuation

Humana AB has a market cap or net worth of GBP 175.26 million. The enterprise value is 524.36 million.

Market Cap	175.26M
Enterprise Value	524.36M

Important Dates

The last earnings date was Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	May 7, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+4.89%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	29.61M

Valuation Ratios

The trailing PE ratio is 16.86.

PE Ratio	16.86
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.60, with an EV/FCF ratio of 12.75.

EV / Earnings	50.45
EV / Sales	0.68
EV / EBITDA	6.60
EV / EBIT	14.52
EV / FCF	12.75

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.56.

Current Ratio	0.87
Quick Ratio	0.63
Debt / Equity	1.56
Debt / EBITDA	4.82
Debt / FCF	9.04
Interest Coverage	1.66

Financial Efficiency

Return on equity (ROE) is 4.66% and return on invested capital (ROIC) is 3.62%.

Return on Equity (ROE)	4.66%
Return on Assets (ROA)	2.94%
Return on Invested Capital (ROIC)	3.62%
Return on Capital Employed (ROCE)	6.16%
Revenue Per Employee	60,880
Profits Per Employee	851
Employee Count	12,212
Asset Turnover	1.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +69.88% in the last 52 weeks. The beta is 0.58, so Humana AB's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+69.88%
50-Day Moving Average	37.31
200-Day Moving Average	34.75
Relative Strength Index (RSI)	80.71
Average Volume (20 Days)	4,598

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Humana AB had revenue of GBP 743.46 million and earned 10.39 million in profits. Earnings per share was 0.21.

Revenue	743.46M
Gross Profit	164.27M
Operating Income	35.08M
Pretax Income	14.07M
Net Income	10.39M
EBITDA	40.56M
EBIT	35.08M
Earnings Per Share (EPS)	0.21

Full Income Statement

Balance Sheet

The company has 42.08 million in cash and 371.69 million in debt, giving a net cash position of -329.62 million.

Cash & Cash Equivalents	42.08M
Total Debt	371.69M
Net Cash	-329.62M
Net Cash Per Share	n/a
Equity (Book Value)	237.60M
Book Value Per Share	4.40
Working Capital	-25.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 62.72 million and capital expenditures -21.58 million, giving a free cash flow of 41.14 million.

Operating Cash Flow	62.72M
Capital Expenditures	-21.58M
Free Cash Flow	41.14M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.09%, with operating and profit margins of 4.72% and 1.40%.

Gross Margin	22.09%
Operating Margin	4.72%
Pretax Margin	1.89%
Profit Margin	1.40%
EBITDA Margin	5.46%
EBIT Margin	4.72%
FCF Margin	5.53%

Dividends & Yields

Humana AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.89%
Shareholder Yield	-4.89%
Earnings Yield	5.93%
FCF Yield	23.47%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Humana AB has an Altman Z-Score of 1.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.46
Piotroski F-Score	n/a